Literature DB >> 24824093

Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma.

Min Jung Lee1, Paige Wickner, Laura Fanning, Robert Schlossman, Paul Richardson, Jacob Laubach, Maria Castells.   

Abstract

Entities:  

Keywords:  allergy; desensitization; lenalidomide; multiple myeloma; myeloma therapy

Mesh：

Substances：

Year:  2014        PMID： 24824093     DOI： 10.1111/bjh.12925

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  Supportive care in multiple myeloma: Current practices and advances.

Authors:  Teresa S Miceli; Wilson I Gonsalves; Francis K Buadi
Journal:  Cancer Treat Res Commun       Date:  2021-10-09

Review 2.  Common Adverse Effects of Novel Therapies for Multiple Myeloma (MM) and Their Management Strategies.

Authors:  Kristen B McCullough; Miriam A Hobbs; Jithma P Abeykoon; Prashant Kapoor
Journal:  Curr Hematol Malig Rep       Date:  2018-04       Impact factor: 3.952

Review 3.  Cancer therapies based on targeted protein degradation - lessons learned with lenalidomide.

Authors:  Max Jan; Adam S Sperling; Benjamin L Ebert
Journal:  Nat Rev Clin Oncol       Date:  2021-03-02       Impact factor: 66.675

4.  Interleukin-10 is increased in successful drug desensitization regardless of the hypersensitivity reaction type.

Authors:  Aslı Gelincik; Semra Demir; Fatma Şen; Uğur Hamza Bozbey; Müge Olgaç; Derya Ünal; Bahauddin Çolakoğlu; Esin Çetin Aktaş; Günnur Deniz; Suna Büyüköztürk
Journal:  Asia Pac Allergy       Date:  2019-01-28

5.  Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies.

Authors:  Arantza Vega; M Isabel Peña; Inés Torrado
Journal:  Front Allergy       Date:  2022-01-14

6.  Lenalidomide Desensitization in Systemic Light-Chain Amyloidosis With Multi-Organ Involvement.

Authors:  Jack T Seki; Naoko Sakurai; Vishal Kukreti
Journal:  J Clin Med Res       Date:  2015-08-23

Review 7.  Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network.

Authors:  Heinz Ludwig; Michel Delforge; Thierry Facon; Hermann Einsele; Francesca Gay; Philippe Moreau; Hervé Avet-Loiseau; Mario Boccadoro; Roman Hajek; Mohamad Mohty; Michele Cavo; Meletios A Dimopoulos; Jesús F San-Miguel; Evangelos Terpos; Sonja Zweegman; Laurent Garderet; María-Victoria Mateos; Gordon Cook; Xavier Leleu; Hartmut Goldschmidt; Graham Jackson; Martin Kaiser; Katja Weisel; Niels W C J van de Donk; Anders Waage; Meral Beksac; Ulf H Mellqvist; Monika Engelhardt; Jo Caers; Christoph Driessen; Joan Bladé; Pieter Sonneveld
Journal:  Leukemia       Date:  2018-05-02       Impact factor: 11.528
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.